Search results
Results from the Health.Zone Content Network
400. Website. twistbioscience .com. Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. [2] Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 ...
Emily Leproust is an American scientist and entrepreneur. She is the CEO and co-founder [1] of Twist Bioscience, a public company working on DNA synthesis. The company harnesses synthetic biology, providing tools to manufacture insulin from yeast, to tackle malaria, [2] produce spider silk at scale [3] or store information on DNA.
Twist Bioscience (TWST) delivered earnings and revenue surprises of -7.89% and 7.68%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Here are a few recommendations for biotech ETFs in 2024. 1. VanEck Biotech ETF (BBH) Top five holdings: Amgen, Vertex Pharmaceuticals, Gilead Sciences, Regeneron Pharmaceuticals, Moderna. Average ...
President & CEO of Twist Bioscience Corp (30-Year Financial, Insider Trades) Emily M. Leproust (insider trades) sold 5,000 shares of TWST on 12/22/2020 at an average price of $160.12 a share.
Nicholas J. Pritzker. Nicholas J. Pritzker is an American real estate and venture entrepreneur in San Francisco, California. [1] He served as the Chairman of the board and CEO of the Hyatt Development Corporation. [2] [3] He is a member of the wealthy Pritzker family, who owned chewing-tobacco giant Conwood before selling it to Reynolds American.
Twist Bioscience Corporation ( NASDAQ:TWST ) shareholders might be concerned after seeing the share price drop 29% in...
The National Biodefense Analysis and Countermeasures Center is a unique facility that is crucial to our homeland security, intelligence, and anti-terrorism endeavors. This is the lab that protects us against anthrax attacks, ricin attacks and other bioterrorism threats. In May 2017, several faculty at the Johns Hopkins Center for Health ...